Francisco Durazo

5.8k total citations
87 papers, 3.7k citations indexed

About

Francisco Durazo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Francisco Durazo has authored 87 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hepatology, 60 papers in Epidemiology and 27 papers in Surgery. Recurrent topics in Francisco Durazo's work include Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (41 papers) and Hepatitis C virus research (26 papers). Francisco Durazo is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (41 papers) and Hepatitis C virus research (26 papers). Francisco Durazo collaborates with scholars based in United States, Taiwan and Israel. Francisco Durazo's co-authors include Sammy Saab, Ronald W. Busuttil, Douglas G. Farmer, Myron J. Tong, Steven Han, Hasan Yersiz, Steven Han, Jonathan R. Hiatt, Leonard I. Goldstein and Charles Lassman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Francisco Durazo

85 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Durazo United States 35 2.6k 1.9k 1.6k 278 276 87 3.7k
Paul Gow Australia 31 2.2k 0.9× 1.9k 1.0× 945 0.6× 153 0.6× 284 1.0× 173 3.9k
Sumita Verma United Kingdom 28 1.9k 0.8× 2.0k 1.1× 1.2k 0.8× 163 0.6× 473 1.7× 89 3.4k
Brendan M. McGuire United States 30 2.0k 0.8× 1.4k 0.7× 1.2k 0.8× 268 1.0× 447 1.6× 99 3.4k
Kevork Peltekian Canada 28 1.9k 0.8× 1.7k 0.9× 1.1k 0.7× 401 1.4× 100 0.4× 78 3.2k
Jeffrey S. Crippin United States 31 3.3k 1.3× 2.6k 1.4× 1.3k 0.9× 252 0.9× 1.4k 5.0× 81 5.2k
Alfred L. Baker United States 32 1.3k 0.5× 999 0.5× 1.4k 0.9× 180 0.6× 272 1.0× 87 3.1k
J. Eileen Hay United States 29 2.8k 1.1× 2.1k 1.1× 1.6k 1.0× 342 1.2× 1.4k 5.1× 58 4.7k
Aldo J. Montaño‐Loza Canada 42 4.5k 1.7× 3.6k 1.9× 1.7k 1.1× 85 0.3× 100 0.4× 179 7.5k
Marwan Ghabril United States 35 1.9k 0.8× 1.7k 0.9× 1.4k 0.9× 129 0.5× 760 2.8× 199 4.4k
Alexander Gimson United Kingdom 45 4.5k 1.7× 2.7k 1.4× 3.3k 2.1× 485 1.7× 1.0k 3.7× 100 6.5k

Countries citing papers authored by Francisco Durazo

Since Specialization
Citations

This map shows the geographic impact of Francisco Durazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Durazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Durazo more than expected).

Fields of papers citing papers by Francisco Durazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Durazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Durazo. The network helps show where Francisco Durazo may publish in the future.

Co-authorship network of co-authors of Francisco Durazo

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Durazo. A scholar is included among the top collaborators of Francisco Durazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Durazo. Francisco Durazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durazo, Francisco, et al.. (2022). De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient. SHILAP Revista de lepidopterología. 2022. 1–5. 10 indexed citations
2.
Dong, Tien S., Jonathan P. Jacobs, Vatche G. Agopian, et al.. (2021). Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis. Digestive Diseases and Sciences. 67(8). 3831–3841. 15 indexed citations
3.
Kamal, Natasha, Christopher Koh, Niharika Samala, et al.. (2019). Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis. Hepatology International. 13(5). 641–648. 36 indexed citations
4.
Saab, Sammy, Abbey Barnard, Antony Aziz, et al.. (2018). Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients.. PubMed. 16(4). 419–424. 5 indexed citations
5.
6.
Saab, Sammy, Melissa Jimenez, Jonathan Grotts, et al.. (2017). Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C. Journal of Clinical and Translational Hepatology. XX(XX). 1–8. 9 indexed citations
7.
Saab, Sammy, Melissa Jimenez, Gina Choi, et al.. (2016). Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. Journal of Clinical and Translational Hepatology. 4(1). 32–38. 15 indexed citations
8.
Saab, Sammy, Peter Konyn, Melissa Jimenez, et al.. (2016). Limited Knowledge of Acetaminophen in Patients with Liver Disease. Journal of Clinical and Translational Hepatology. 4(4). 281–287. 14 indexed citations
9.
Lee, Edward, Sammy Saab, Ronald W. Busuttil, et al.. (2016). Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012. Digestive Diseases and Sciences. 61(10). 2838–2846. 5 indexed citations
10.
Chavalitdhamrong, Disaya, Dennis M. Jensen, Thomas O. Kovacs, et al.. (2011). Capsule Endoscopy Is Not as Accurate as Esophagogastroduodenoscopy in Screening Cirrhotic Patients for Varices. Clinical Gastroenterology and Hepatology. 10(3). 254–258.e1. 18 indexed citations
11.
Saab, Sammy, Carmen Landaverde, Sung‐Jae Lee, et al.. (2011). Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transplantation. 17(5). 567–579. 23 indexed citations
12.
Hong, Johnny C., Henrik Petrowsky, Fady M. Kaldas, et al.. (2011). Predictive Index for Tumor Recurrence after Liver Transplantation for Locally Advanced Intrahepatic and Hilar Cholangiocarcinoma. Journal of the American College of Surgeons. 212(4). 514–520. 65 indexed citations
13.
Tong, Myron J., Leeyen Hsu, Jia‐Horng Kao, et al.. (2010). A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International. 4(2). 516–522. 14 indexed citations
14.
Tabibian, James H., Mariana Lazo, Francisco Durazo, et al.. (2010). Nonalcoholic fatty liver disease across ethno‐racial groups: Do Asian‐American adults represent a new at‐risk population?. Journal of Gastroenterology and Hepatology. 26(3). 501–509. 28 indexed citations
15.
Fong, Tse–Ling, Karl C. Klontz, Steven Casper, et al.. (2010). Hepatotoxicity Due to Hydroxycut: A Case Series. The American Journal of Gastroenterology. 105(7). 1561–1566. 106 indexed citations
16.
Yan, Eric, Francisco Durazo, Myron J. Tong, & Kurt Hong. (2008). Nonalcoholic Fatty Liver Disease: Pathogenesis, Identification, Progression, and Management. Nutrition Reviews. 65(8). 376–384. 45 indexed citations
17.
Saab, Sammy, Ayman Ibrahim, Francisco Durazo, et al.. (2007). Employment and quality of life in liver transplant recipients. Liver Transplantation. 13(9). 1330–1338. 67 indexed citations
18.
Saab, Sammy, Ayman Ibrahim, Zobair M. Younossi, et al.. (2005). MELD fails to measure quality of life in liver transplant candidates. Liver Transplantation. 11(2). 218–223. 94 indexed citations
19.
Farmer, Douglas G., Dean M. Anselmo, R. Mark Ghobrial, et al.. (2003). Liver Transplantation for Fulminant Hepatic Failure. Annals of Surgery. 237(5). 666–676. 131 indexed citations
20.
Saab, Sammy, et al.. (2003). Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. The American Journal of Gastroenterology. 98(4). 763–770. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Gow Breakdown of academic impact, for papers by Sumita Verma Breakdown of academic impact, for papers by Brendan M. McGuire Breakdown of academic impact, for papers by Kevork Peltekian Breakdown of academic impact, for papers by Jeffrey S. Crippin Breakdown of academic impact, for papers by Alfred L. Baker Breakdown of academic impact, for papers by J. Eileen Hay Breakdown of academic impact, for papers by Aldo J. Montaño‐Loza Breakdown of academic impact, for papers by Marwan Ghabril Breakdown of academic impact, for papers by Alexander Gimson
Rankless by CCL
2026